This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Caterina Noula
Introduction
Caterina Noula, an accomplished inventor located in St. Columb Major, Great Britain, has made significant strides in the field of medicinal chemistry. With a focus on anti-inflammatory compounds, her work has the potential to lead to advancements in the treatment of diseases mediated through key inflammatory pathways.
Latest Patents
Caterina Noula holds a patent for "2,4,5-trisubstituted thiazolyl derivatives and their anti-inflammatory activity." This invention describes various compounds that may be used as pharmaceuticals for preventing or treating diseases involving tumor necrosis factor alpha (TNF-α) and interleukin-12 (IL-12). The compound's versatility includes structural modifications such as N-oxide forms and a range of substituents that enhance its therapeutic profile.
Career Highlights
Currently, Caterina is a key member of Janssen Pharmaceutica NV, where her research contributes to the development of novel medicinal treatments. Her patent stands as a testament to her innovative approach in the pharmaceutical sector, showcasing her ability to translate scientific research into practical applications.
Collaborations
Caterina Noula has collaborated with notable professionals in the industry, including Christopher John Love and Jean Pierre Frans Van Wauwe. These partnerships underscore the collaborative spirit of innovation prevalent in the pharmaceutical field, facilitating the sharing of ideas and expertise towards achieving groundbreaking results.
Conclusion
Caterina Noula is a pioneering inventor whose work exemplifies the critical role of innovation in healthcare. With her patent focusing on anti-inflammatory compounds, she continues to shape the future of medicine through her contributions to Janssen Pharmaceutica NV and her collaborations with industry experts. As the demand for effective treatments for inflammatory diseases grows, Noula’s inventive spirit stands as a beacon of hope for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile